13F-HR filed by BVF INC/IL
BVF INC/IL filed this 13F-HR for the quarter ended 2016-09-30, filed 2016-11-14, with 29 holding rows worth $530,675,000.
- Accession
- 0000921895-16-006168
- Filer
- CIK 1056807
- Filed
- 2016-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2016
A holdings report, 29 entries on the cover page, a total value of $530,675,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $530,675,000 with VALUE read as thousands by filing date, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBVF PARTNERS L P/IL028-06770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 2,765,080 | $82,123,000 | thousands by filing date | |
| CHEMOCENTRYX INC | 16383L106 | COM | 8,064,019 | $48,707,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 4,997,071 | $45,873,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 6,461,186 | $43,613,000 | thousands by filing date | |
| CASCADIAN THERAPEUTICS INC COM | 14740B101 | Stock | 18,799,368 | $30,831,000 | thousands by filing date | |
| FORWARD PHARMA A/S | 34986J105 | SPONSORED ADR | 1,387,853 | $29,145,000 | thousands by filing date | |
| COLUCID PHARMACEUTICALS INC | 19716T101 | COM | 763,300 | $29,120,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 2,723,210 | $27,532,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 3,108,905 | $25,182,000 | thousands by filing date | |
| ONCOMED PHARMACEUTICALS INC COM | 68234X102 | Stock | 1,812,005 | $20,711,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 2,426,282 | $17,348,000 | thousands by filing date | |
| CTI BIOPHARMA CORP COM NEW | 12648L106 | Stock | 44,796,940 | $16,767,000 | thousands by filing date | |
| TOBIRA THERAPEUTICS INC COM | 88883P101 | COM | 399,433 | $15,873,000 | thousands by filing date | |
| NIVALIS THERAPEUTICS INC | 65481J109 | COM | 1,709,673 | $13,900,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 7,400,128 | $13,246,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 591,813 | $9,280,000 | thousands by filing date | |
| IMMUNE DESIGN CORP. | 45252L103 | Common Stock | 1,200,000 | $9,096,000 | thousands by filing date | |
| GTX INC | 40052B108 | COM | 11,512,000 | $9,014,000 | thousands by filing date | |
| INFINITY PHARMACEUTICALS INC | 45665G303 | COM | 5,149,644 | $8,033,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 375,000 | $7,924,000 | thousands by filing date | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 493,872 | $6,840,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 501,155 | $6,229,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328700 | COM | 730,361 | $3,192,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164AB0 | NOTE 2.750%12/0 | 10,000,000 | $2,650,000 | thousands by filing date | principal |
| OREXIGEN THERAPEUTICS INC COM NEW | 686164302 | Stock | 734,976 | $2,440,000 | thousands by filing date | |
| PAIN THERAPEUTICS INC | 69562K100 | COM | 2,278,552 | $2,278,000 | thousands by filing date | |
| PIERIS PHARMACEUTICALS INC | 720795103 | COM | 1,016,593 | $1,858,000 | thousands by filing date | |
| CATALYST | 14888D109 | COM | 865,773 | $1,048,000 | thousands by filing date | |
| GLOBEIMMUNE INC | 37957B100 | COM | 657,653 | $822,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000921895-16-006168 | this filing | 2016-11-14 | acceptance time not in the bulk data set |